Siegfried Holding AG (XSWX:SFZN) Moat Score: 6/10 (As of Jul. 01, 2026)


XSWX:SFZN Siegfried Holding AG XSWX:SFZN
94 GF Score
Price CHF70.80
GF Value CHF92.02
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Siegfried Holding AG Moat Score?

Siegfried Holding AG XSWX:SFZN +1.29% 94 Moat Score is 6 as of Jul. 01, 2026. GuruFocus rates XSWX:SFZN with a GF Score™ of 94/100 and a GF Value™ of CHF92.02 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 1,031 Drug Manufacturers companies, Siegfried Holding AG ranks better than 97.09% on this metric.

Siegfried Holding AG has the Moat Score of 6, which implies that the company might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

Siegfried Holding AG has Narrow Moat: Siegfried Holding has a strong narrow moat due to its specialized pharmaceutical manufacturing capabilities and economies of scale. It benefits from regulatory barriers and a strong distribution network. However, it lacks the extensive brand strength or network effects needed for a wide moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Siegfried Holding AG might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

Siegfried Holding AG  (XSWX:SFZN) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Siegfried Holding AG Moat Score Related Terms

XSWX:SFZN vs ZTS, UTHR, VTRS: Moat Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Siegfried Holding AG's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Siegfried Holding AG Moat Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Siegfried Holding AG's Moat Score distribution charts can be found below:

* The bar in red indicates where Siegfried Holding AG's Moat Score falls into.


XSWX:SFZN
94GF Score
Siegfried Holding AG XSWX:SFZN
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 6 mean?
Siegfried Holding AG (XSWX:SFZN) has a Moat Score of 6 as of Jul. 01, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Siegfried Holding AG ranks #30 out of 1031 companies in the Drug Manufacturers industry, placing it in the top 2.9%.
Is Siegfried Holding AG's Moat Score too high?
Siegfried Holding AG's current Moat Score is 6. Based on the distribution chart, Siegfried Holding AG ranks #30 out of 1031 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Siegfried Holding AG has a GF Score™ of 94/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Siegfried Holding AG's Moat Score compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Siegfried Holding AG ranks #30 out of 1031 companies for Moat Score. This places Siegfried Holding AG in the top 3% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Drug Manufacturers company?
A good Moat Score depends on the Drug Manufacturers industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Siegfried Holding AG's current Moat Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Siegfried Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Siegfried Holding AG (XSWX:SFZN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF92.02, compared to a current price of CHF70.80 — trading 23.1% below its estimated fair value. The current Moat Score is 6. Siegfried Holding AG's overall GF Score™ is 94/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Siegfried Holding AG (XSWX:SFZN), the current Moat Score is 6 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Siegfried Holding AG (XSWX:SFZN) Overvalued in 2026?

Based on GuruFocus' analysis, Siegfried Holding AG stock appears to be undervalued. The current stock price of CHF70.80 is trading 23.1% below its estimated GF Value™ of CHF92.02. GuruFocus considers Siegfried Holding AG to be Modestly Undervalued.

Key valuation signals for XSWX:SFZN:

  • Moat Score: 6
  • GF Value™: CHF92.02 vs. price of CHF70.80 (23.1% below fair value)
  • GF Score™: 94/100 with 2 warning signs

No single metric tells the full story. See the XSWX:SFZN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Siegfried Holding AG Business Description

Address Untere Bruehlstrasse 4, Zofingen, CHE, CH-4800
Siegfried is a global contract development and manufacturing organization. It derives its revenue primarily from long-term supply agreements with biotechnology and pharmaceutical customers. Siegfried develops and manufactures active pharmaceutical ingredients, finished dosage forms (tablets, capsules, sterile vials, ampules, cartridges, and ointments), and viral vectors. The company provides these services throughout the entire drug lifecycle, including chemical and analytical development, pilot manufacturing, and commercial-scale manufacturing. Siegfried has a large global footprint with 13 production sites on three continents.
94GF Score

Get the complete analysis for XSWX:SFZN

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF70.80
Price
CHF92.02
GF Value